Marcio M. Amaral

Rio De Janeiro, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Impact of GLP-1 Receptor Agonist Discontinuation on Liver-Related Parameters: A Systematic Review and Meta-Analysis.

Impact of GLP-1 Receptor Agonist Discontinuation on Liver-Related Parameters: A Systematic Review and Meta-Analysis.

Journal: Diabetes, obesity & metabolism

Published: January 10, 2026

Epidemiology and Clinical Characteristics of Fatty Pancreas Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review.

Epidemiology and Clinical Characteristics of Fatty Pancreas Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review.

Journal: Journal of gastroenterology and hepatology

Published: January 06, 2026

Higher consumption of ultra-processed foods and long-term risk of metabolic dysfunction-associated steatotic liver disease and primary liver cancer: A meta-analysis of preliminary evidence.

Higher consumption of ultra-processed foods and long-term risk of metabolic dysfunction-associated steatotic liver disease and primary liver cancer: A meta-analysis of preliminary evidence.

Journal: Clinical nutrition ESPEN

Published: May 15, 2025

A systematic review & updated meta-analysis on the association between higher consumption of ultra processed foods and risk of diabetes and its complications: Response Letter.

A systematic review & updated meta-analysis on the association between higher consumption of ultra processed foods and risk of diabetes and its complications: Response Letter.

Journal: Metabolism: clinical and experimental

Published: February 05, 2025

Prevalence, clinical characteristics, and outcomes of fatty pancreas disease: an updated systematic review and meta-analysis.

Prevalence, clinical characteristics, and outcomes of fatty pancreas disease: an updated systematic review and meta-analysis.

Journal: European journal of gastroenterology & hepatology

Published: November 26, 2024

Response and Adverse Event Rates With Placebo in Compensated MASH-related Cirrhosis: A Meta-analysis.

Response and Adverse Event Rates With Placebo in Compensated MASH-related Cirrhosis: A Meta-analysis.

Journal: Journal of clinical and experimental hepatology

Published: November 22, 2024

Association between higher consumption of ultra-processed foods and risk of diabetes and its complications: A systematic review & updated meta-analysis.

Association between higher consumption of ultra-processed foods and risk of diabetes and its complications: A systematic review & updated meta-analysis.

Journal: Metabolism: clinical and experimental

Published: October 28, 2024

Prevalence of MASLD in children and adolescents with type 1 diabetes: A meta-analysis.

Prevalence of MASLD in children and adolescents with type 1 diabetes: A meta-analysis.

Journal: Diabetes, obesity & metabolism

Published: October 03, 2024

Meta-Analysis of Placebo-Treated Patients: Dropout Rates From Treatment in MASH Randomised Controlled Trials.

Meta-Analysis of Placebo-Treated Patients: Dropout Rates From Treatment in MASH Randomised Controlled Trials.

Journal: Alimentary pharmacology & therapeutics

Published: August 06, 2024

Lean MASLD: are overweight or obese people with MASLD 'protected' from CVD mortality?

Lean MASLD: are overweight or obese people with MASLD 'protected' from CVD mortality?

Journal: Current problems in cardiology

Published: April 10, 2024

Showing 1-10 of 10

Last Updated: 09/26/2026